(Q38038687)

27 August 2017

title

Biology of Factor XIII and clinical manifestations of Factor XIII deficiency (English)

1 reference

27 August 2017

Jerrold H Levy

1

1 reference

27 August 2017

Charles Greenberg

series ordinal

2

1 reference

27 August 2017

publication date

28 August 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

53

1 reference

27 August 2017

issue

5

1 reference

27 August 2017

page(s)

1120-1131

1 reference

Introduction. Rare bleeding disorders: general aspects of clinical features, diagnosis, and management

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Molecular and genetic mechanisms of factor XIII A subunit deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Congenital factor XIII deficiency caused by two mutations in eight Tunisian families: molecular confirmation of a founder effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Hemorrhagic acquired factor XIII (13) deficiency and acquired hemorrhaphilia 13 revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Acquired factor XIII inhibitor: clinical features, treatment, fibrin structure and epitope determination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Practolol therapy associated with a systemic lupus erythematosus-like syndrome and an inhibitor to factor XIII

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Expression and release of the a and b subunits for human coagulation factor XIII in baby hamster kidney (BHK) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Association of coagulation factor XIII-A with Golgi proteins within monocyte-macrophages: implications for subcellular trafficking and secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Factor XIII: a coagulation factor with multiple plasmatic and cellular functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Isolation of a fibrin-binding fragment from blood coagulation factor XIII capable of cross-linking fibrin(ogen)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Sushi domains in the B subunit of factor XIII responsible for oligomer assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Interactions between factor XIII and the alphaC region of fibrinogen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Factor XIII: inherited and acquired deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Fibrin stabilization (factor XIII), fibrin structure and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

The antifibrinolytic function of factor XIII is exclusively expressed through α₂-antiplasmin cross-linking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Coagulation factor XIII variants with altered thrombin activation rates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

FXIII polymorphisms, fibrin clot structure and thrombotic risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Identification of eight novel coagulation factor XIII subunit A mutations: implied consequences for structure and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

An update of the mutation profile of Factor 13 A and B genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

21 January 2018

Factor XIII deficiency

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Intracranial haemorrhage in patients with congenital haemostatic defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Management of pregnancy, labour and delivery in women with inherited bleeding disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Role of fibrinogen levels and factor XIII V34L polymorphism in thrombolytic therapy in stroke patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Tyr204Phe and Val34Leu polymorphisms in two Brazilian ethnic groups and in patients with recurrent miscarriages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Prevalence of the coagulation factor XIII polymorphism Val34Leu in women with recurrent miscarriage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Coagulation factor XIII and markers of thrombin generation and fibrinolysis in patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Factor XIII in chronic inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Factor XIII deficiency and postoperative hemorrhage after neurosurgical procedures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Problems relating to the laboratory diagnosis of factor XIII deficiency: a UK NEQAS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Diagnostic and genetic studies on fibrin-stabilizing factor with a new assay based on amine incorporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

A filter paper assay for transamidating enzymes using radioactive amine substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

A microtiter assay for factor XIII using fibrinogen and biotinylcadaverine as substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Evaluation of a sensitive colorimetric FXIII incorporation assay. Effects of FXIII Val34Leu, plasma fibrinogen concentration and congenital FXIII deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Diagnosis and classification of factor XIII deficiencies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

A highly sensitive chemiluminescence immunoassay for the measurement of coagulation factor XIII subunits and their complex in tears.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Factor XIII--an under diagnosed deficiency--are we using the right assays?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

A microtiter plate assay for factor XIII A-chain-fibrin interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

A reversed activity staining procedure for detection of an acquired antibody against factor XIII in a girl with factor XIII deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Prophylactic therapy with Fibrogammin P is associated with a decreased incidence of bleeding episodes: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Congenital blood coagulation factor XIII deficiency and perinatal management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Safety, pharmacokinetics, and immunogenicity of single-dose rFXIII administration to healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

Recurrent miscarriage syndrome and infertility due to blood coagulation protein/platelet defects: a review and update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2012.03865.X

10.1111/J.1537-2995.2012.03865.X

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference